CHM chimeric therapeutics limited

Ann: AML patient achieves Complete Response in CHM CORE-NK trial, page-33

  1. 297 Posts.
    lightbulb Created with Sketch. 92
    the eligibility criteria for phase 2 of RACs - AML trial was at least 1 prior line of therapy. you may be confusing the number of prior lines with the 7+3 protocol (7 days for chemo A then 3 days of chemo B)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $6.045M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $22.28K 6.311M

Buyers (Bids)

No. Vol. Price($)
78 84735861 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 86304338 23
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.